Differential Immune Response to Attenuated Rubella Virus Vaccine
AUTOR(ES)
Gupta, Jiban D.
RESUMO
Serum samples collected from 18 volunteers 1, 2, and 3 months after vaccination with Cendehill strain of attenuated rubella virus vaccine were fractionated on a Sephadex G-200 column to test for immunoglobulin M (IgM) antibody. Seventeen of the 18 had demonstrable IgM antibody in serum collected 1 month postvaccination whereas only 5 and 3 had IgM antibody 2 and 3 months, respectively, post-inoculation. The geometric mean titers of hemagglutination-inhibiting antibody in the 19S fraction were 38, 7, and 6 at 1, 2, and 3 months after vaccination, whereas the corresponding 7S titers were 29, 53, and 57, respectively. Four other seronegative volunteers vaccinated with Cendevax were tested serially for total antibody only in whole blood obtained by finger pricks. Three of them showed appearance of antibody between 14 and 17 days and one between 17 and 21 days. It appears that vaccine-induced immune response is similar to natural infection especially with regard to the time of appearance of antibody and the relative proportions of IgM and IgG antibody thus produced.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422338Documentos Relacionados
- Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.
- Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
- Chronic stress alters the immune response to influenza virus vaccine in older adults.
- Differential Immune Responses to Primary Measles-Mumps-Rubella Vaccination in Israeli Children
- Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.
